Skip to main content
Tech.euFundingExplorerBeta

Minoryx Therapeutics

Develops novel therapies for pediatric genetic diseases

Minoryx Therapeutics has raised €74M across 4 funding rounds from 6 investors, most recently a Series C round in May 2022. Based in Mataró, Spain; founded 2011; active in Healthtech. Data as of 28 Oct 2026.

Mataró, SpainFounded 2011minoryx.com ↗
Total raised
€74M
€73,500,000
Funding rounds
4
Investors
6
distinct backers
Active since
2013-04
latest 2022-05

Funding by year

EUR raised per year
Minoryx Therapeutics — funding by year — interactive chart.
Data table
Minoryx Therapeutics — funding by year
2013€1.5M
2014€1.6M
2015€19M
2022€51M

Signals

High confidence
Raise-next likelihood10
base rate 50% for Series C
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds

Related news

Similar companies

same sector or country

Global coverage: FundingData